Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer

被引：0
|
作者：
Mansure, Jose [1 ]
Nassim, Roland [1 ]
Rocha, Joice [1 ]
Scarlata, Eleonora [1 ]
Chevalier, Simone [1 ]
Kassouf, Wassim [1 ]
机构：
[1] McGill, Montreal, PQ, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2879
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases
    Avileen Kaur
    Saurabh Sharma
    Inflammopharmacology, 2017, 25 : 293 - 312
  • [32] Targeting the Mammalian Target of Rapamycin in Lung Cancer
    Vicary, Glenn W.
    Roman, Jesse
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (05): : 507 - 516
  • [33] Cancer and transplantation intersect at the mammalian target of rapamycin
    MacDonald, Allan S.
    TRANSPLANTATION, 2007, 84 (06) : 682 - 684
  • [34] The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention
    Kopelovich, Levy
    Fay, Judith R.
    Sigman, Caroline C.
    Crowell, James A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (07) : 1330 - 1340
  • [35] Mammalian target of rapamycin
    Meric-Bernstam, F
    Mills, GB
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 10 - 17
  • [36] Mammalian target of rapamycin (mTOR) inhibitors with therapeutic potential for colitis
    Deore, Vijaykumar
    Bhonde, Mandar R.
    Vishwakarma, Ram A.
    Dagia, Nilesh M.
    Kumar, Sanjay
    Roychowdhury, Abhijit
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2009, 48 (12): : 1761 - 1765
  • [37] Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis
    Nakahara, Tsutomu
    Morita, Akane
    Yagasaki, Rina
    Mori, Asami
    Sakamoto, Kenji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (12) : 2045 - 2049
  • [38] Preventive and therapeutic effects of rapamycin, a mammalian target of rapamycin inhibitor, on food allergy in mice
    Yamaki, K.
    Yoshino, S.
    ALLERGY, 2012, 67 (10) : 1259 - 1270
  • [39] Bone effects of mammalian target of rapamycin (mTOR) inhibition with everolimus
    Hadji, Peyman
    Coleman, Robert
    Gnant, Michael
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 101 - 111
  • [40] Clinical Monitoring Challenges in the Pharmacological Treatment and Management of Lymphatic Anomalies With Mammalian Target of Rapamycin Inhibition
    Triana, Paloma
    Miguel, Miriam
    Diaz, Mercedes
    Carlos Lopez-Gutierrez, Juan
    THERAPEUTIC DRUG MONITORING, 2019, 41 (04) : 547 - 548
12345